Skip to content

Evaluation of Marginal, Internal Adaptation and Clinical Performance of Endo-crowns Fabricated From Nano Hybrid and Lithium Di-silicate Ceramic Materials.

Evaluation of Marginal and Internal Adaptation and Clinical Performance of Endo-crowns Fabricated From Nano-ceramic Hybrid and Lithium Di-silicate Ceramic Materials (A Randomized Controlled Clinical Trial)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04737005
Enrollment
28
Registered
2021-02-03
Start date
2021-02-01
Completion date
2022-03-01
Last updated
2021-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical Fit and Clinical Performance

Brief summary

Evaluation of the marginal and internal adaptation using silicon replica technique, which will be measured by digital microscope and clinical Performance using modified USPHS scoring system of Endo-crowns fabricated from Nano-ceramic Hybrid and Lithium di-silicate ceramic materials.

Detailed description

Evaluation of the marginal and internal adaptation using silicon replica technique, which will be measured by digital microscope and clinical Performance using modified USPHS scoring system of Endo-crowns fabricated from Nano-ceramic Hybrid and Lithium di-silicate ceramic materials. Primary outcome: Marginal gap of the two groups will be measured using Silicon replica technique, Each replica will be sectioned bucco-lingually and mesio-distally into four segments named (MB, DB, ML, DL) and each segment has five reference points assigned at different positions, An overall of twenty reference points will be measured in each replica sample using a digital microscope. Secondary outcome: * Internal gap of the two groups will be measured using Silicon replica technique, which will be measured by digital microscope. * Clinical Performance of the two groups will be evaluated using modified USPHS scoring system. (Color match, Marginal discoloration, Surface texture and Gross fracture)

Interventions

PROCEDURENano-ceramic hybrid (Grandio Blocs) Endo-crown

Nano-ceramic hybrid

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* From 18-50 years old, be able to read and sign the informed consent document. * Have no active periodontal or pulpal diseases, have teeth with good restorations. * Psychologically and physically able to withstand conventional dental procedures. * Patients planned for a single coverage restoration in the posterior area. * Able to return for follow-up examinations and evaluation. * Patients have root apex of molar without evident damage and no root fracture. * Good oral hygiene habits. * Have a complete root canal therapy molar necessitating an Endo-crown restoration.

Exclusion criteria

* Patient less than 18 or more than 50 years * Patients with severe clenching or bruxism. * Patient with active resistant periodontal diseases * Patients with poor oral hygiene and uncooperative patients * Pregnant women * Patients in the growth stage with partially erupted teeth * Psychiatric problems or unrealistic expectations * Patients with inadequate or low quality endodontic treatment.

Design outcomes

Primary

MeasureTime frameDescription
Marginal and internal gap evaluation1 yearmarginal and internal gap will be evaluated by silicon replica technique, each replica will be sectioned into four segments named (MB, DB, ML, DL) and each segment had five reference points assigned at different positions, an overall of twenty reference points will be measured in each replica sample using a digital microscope. The measuring unit by microns

Secondary

MeasureTime frameDescription
clinical performance(Color match, Marginal discoloration, Surface texture and Gross fracture)1 yearClinical performance will be measured by modified USPHS criteria and the measuring unit by Alpha (A), Bravo (B) and Charlie (C)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026